Genitourinary Radiology: Page 16

EDAP debuts HIFU for prostate cancer

By AuntMinnieEurope.com staff writers

French therapeutic ultrasound developer EDAP TMS has launched Focal.One, a new robotic high-intensity focused ultrasound (HIFU) device dedicated to focal therapy of prostate cancer. The product will make its debut at the annual congress of the European Association of Urology being held in Milan on 15-19 March.

March 14, 2013

Median announces 633,000 euro study award

By AuntMinnieEurope.com staff writers

Imaging software developer Median Technologies has received a 633,000 euro award to provide imaging services in a phase II clinical trial for prostate cancer, the company said.

March 12, 2013

Apply Formula 1-type methods to smooth the way in urogenital emergencies

By Edna Astbury-Ward, PhD

VIENNA - There is no single gold standard for training medical teams, but it can pay off to adapt team-working principles from other high-reliability industries such as Formula 1 racing, and integrate them into crisis resource management training, according to a presentation by emergency room radiologists on Monday at ECR 2013.

March 10, 2013

Prepare for the transformation of care by prostate MR imaging

By Edna Astbury-Ward, PhD

VIENNA - Some urologists continue to persist with the old methods of prostate biopsy and tumor detection, despite the benefits of MRI in visualizing the most aggressive parts of prostate tumor. But the situation is changing fast, according Dr. Jelle Barentsz, PhD, of University Hospital Nijmegen in the Netherlands, in a session on Friday at ECR 2013.

March 7, 2013

ESR expects 20,000 delegates at ECR 2013

By AuntMinnieEurope.com staff writers

The European Society of Radiology (ESR) anticipates that around 20,000 participants from 100 countries will attend the European Congress of Radiology (ECR) 2013, its five-day annual meeting that begins in Vienna on 7 March.

February 7, 2013

C-11 choline PET/MRI helps restage prostate cancer patients

By Wayne Forrest

A preliminary study by German researchers suggests that carbon-11 (C-11) choline PET/MRI may provide an alternative imaging modality to PET/CT for restaging of prostate cancer by offering equal, if not better, diagnostic performance and less radiation exposure.

January 16, 2013

Urology residents lack awareness of radiation exposure

By Cynthia E. Keen

Urology residents in Europe are shockingly unaware of the dangers of radiation exposure and the importance of using radiation protection when performing fluoroscopy-guided endourologic procedures, if results from a survey of members of the European Society of Residents in Urology are indicative of the group.

January 6, 2013

CADx may improve diagnosis of central gland prostate cancer

By Erik L. Ridley

Computer-aided diagnosis (CADx) shows potential as a tool to aid radiologists in the challenging task of finding cancer originating from the prostate's central gland, according to Dutch research presented at the 2012 RSNA meeting in Chicago.

December 9, 2012

Mauna's UroFlex receives CE Mark

By AuntMinnieEurope.com staff writers

Mauna Kea Technologies' UroFlex confocal miniprobe has received CE Mark approval for use during cystoscopy procedures.

December 6, 2012

10-year prostate cancer outcomes show rad therapy's benefit

By Cynthia E. Keen

Ten-year clinical outcomes for prostate cancer patients participating in a trial comparing postoperative radiotherapy with observation only show that patients who were irradiated had significantly improved biochemical progression-free survival and local control.

October 18, 2012

SNM: New therapy extends life for prostate cancer patients

By AuntMinnieEurope.com staff writers

Survival is bleak for prostate cancer patients with advanced tumors that have spread to the bone, but a radioisotope procedure being evaluated in a clinical trial is extending lives by several months, according to a study presented at the Society of Nuclear Medicine (SNM) annual meeting, being held in Miami Beach, FL, this week.

June 10, 2012

Accuray begins PACE prostate study

By AuntMinnieEurope.com staff writers

Radiation therapy firm Accuray has launched the Prostate Advances in Comparative Evidence (PACE) study.

April 26, 2012

Previous Page

Page 16 of 22

Next Page